Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks trim losses on Greek hopes, Chinese stimulus

Wed, 04th Feb 2015 17:09

A late rally helped the FTSE 100 to erase most of its losses on Wednesday as optimism surrounding Greece and stimulus measures in China lifted sentiment, though stocks still finished in the red after hitting a five-month high the previous day.London's Footsie ended the session down 0.2% at 6,860.02, bouncing strongly in the last couple of hours after hitting an intraday low of 6,804.10, with pharma heavyweight Glaxosmithkline rising after its results announcement.Greece's prime minister Alexis Tsipras said in a press conference that he believes a debt relief deal can be met without the country leaving the EU. Tsipras said despite not having a deal yet, the country is "moving in the right direction".The prime minister travelled to Brussels to propose the new government's debt-swap plan to EU Commission president Jean-Claude Juncker. Greece has backed down from calling for a total debt write-off and has instead proposed swapping outstanding debt for new growth-linked bonds.Meanwhile, Greek finance minister Yanis Varoufakis, who held a meeting in Frankfurt with European Central Bank head Mario Draghi, said that discussions about easing the terms of the country's bailout were "very fruitful".Elsewhere, the People's Bank of China (PBoC) trimmed the banks' reserve requirement ratio by 50 basis points to 19.5%, the first such cut since May 2012, in an effort to boost lending into the real economy.According to FXTM analyst Jameel Ahmad, the PBoC was the 16th central bank across the globe to ease monetary policy this year in a move that "will be seen by many as a direct response to continued indications of slowing domestic momentum". He said the cut in the reserve requirement will be judged "by the markets as a positive move to reinvigorate economic growth".A raft of service-sector data was released during Wednesday session, showing that growth had picked up in the UK, Eurozone and US but eased in China.Glaxo leads late rallySales, profits and earnings slumped during the last quarter of the year at drugmaker GlaxoSmithKline due to headwinds in the US market, though the company pleased investors after confirming it would return £4bn cash from its deal with Novartis.Others in the pharma sector was also in demand, such as Astrazeneca, Hikma and Synergy Health with the latter benefiting after reporting a solid acceleration in underlying revenue growth in its third quarter.In its first set of results since slimming down its name to Sky and absorbing its German and Italian sister companies, the satellite broadcaster delivered a strong set of interim figures and cited good momentum in all its markets, causing shares to rise.Half-yearly results from fund manager and savings outfit Hargreaves Lansdown showed record assets under administration and growing client numbers, though shares fell sharply after revenues and profits came in shy of City expectations.Oil stocks were stuck in the red as the recent rally in crude prices came to an end with Brent falling 2.9%. Shell, Tullow, Afren and BHP Billiton all declined. Market MoverstechMARK 3,083.09 +0.68%FTSE 100 6,860.02 -0.17%FTSE 250 16,571.64 +0.01%FTSE 100 - RisersITV (ITV) 230.60p +3.64%ARM Holdings (ARM) 1,069.00p +3.09%easyJet (EZJ) 1,778.00p +2.72%Wolseley (WOS) 3,888.00p +1.94%CRH (CRH) 1,779.00p +1.89%Barratt Developments (BDEV) 470.00p +1.78%GlaxoSmithKline (GSK) 1,476.00p +1.58%Ashtead Group (AHT) 1,079.00p +1.41%Burberry Group (BRBY) 1,796.00p +1.41%International Consolidated Airlines Group SA (CDI) (IAG) 542.00p +1.40%FTSE 100 - FallersHargreaves Lansdown (HL.) 966.00p -7.56%Tullow Oil (TLW) 395.90p -5.15%Morrison (Wm) Supermarkets (MRW) 181.50p -2.42%Sainsbury (J) (SBRY) 266.70p -2.16%BHP Billiton (BLT) 1,527.00p -2.02%Aggreko (AGK) 1,596.00p -1.84%Anglo American (AAL) 1,150.00p -1.71%BG Group (BG.) 932.00p -1.38%Intertek Group (ITRK) 2,398.00p -1.28%SABMiller (SAB) 3,528.50p -1.27%FTSE 250 - RisersRank Group (RNK) 185.50p +4.80%Petra Diamonds Ltd.(DI) (PDL) 158.20p +4.42%AO World (AO.) 319.50p +4.28%Booker Group (BOK) 153.50p +3.44%Brown (N.) Group (BWNG) 448.60p +3.08%AL Noor Hospitals Group (ANH) 927.50p +3.00%Countrywide (CWD) 496.80p +2.88%Lonmin (LMI) 172.30p +2.62%Ultra Electronics Holdings (ULE) 1,778.00p +2.48%Howden Joinery Group (HWDN) 425.10p +2.46%FTSE 250 - FallersAfren (AFR) 11.10p -6.25%Premier Oil (PMO) 161.10p -5.79%Hunting (HTG) 456.20p -4.70%Wood Group (John) (WG.) 596.00p -4.03%Aveva Group (AVV) 1,390.00p -3.67%Ladbrokes (LAD) 120.10p -3.15%Thomas Cook Group (TCG) 126.10p -3.00%Interserve (IRV) 541.50p -2.96%Diploma (DPLM) 755.50p -2.58%Petrofac Ltd. (PFC) 742.50p -2.24%
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.